Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes.

Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes.
复制标题

DOI:
10.2337/dc13-0294
复制
发表时间:
2013-10
期刊:
影响因子:
16.2
通讯作者:
Keenan HA
Keenan HA
中科院分区:
医学1区
文献类型:
--
作者:
Turek SJ;Hastings SM;Sun JK;King GL;Keenan HA

文献摘要

参考文献

被引文献

相似文献

Vascular dysfunction is a major contributor to diabetes complications. It is also the primary physiologic cause of erectile dysfunction and considered an independent predictor of cardiovascular disease (CVD) in males over age 40 years. A cohort of individuals with 50 or more years of type 1 diabetes, Joslin Medalists, have low rates of small but not large vessel complications. This study aims to identify the prevalence and longitudinal association of sexual dysfunction (SD) with CVD in Joslin Medalists. Description and association of self-assessment of SD in males of the Medalist cohort by self-reported sexual problems with CVD. SD is validated through the use of the abbreviated International Index of Erectile Dysfunction (IIEF). Of 301 males in the Medalist Study, 69.8% reported a history of SD. Unadjusted risk factors included elevated glycated hemoglobin (HbA1c) (P = 0.02), elevated BMI (P = 0.03), higher total cholesterol (P = 0.02), lower HDL (P < 0.01), and increased levels of interleukin-6 (P = 0.03). SD was independently associated with CVD (age-, HbA1c-, and BMI-adjusted OR 1.9 [95% CI 1.0–3.5]). In adjusted analyses, retinal, neural, and renal complications were not associated (P > 0.05) with SD. Current report of SD (IIEF score ≤17) in a subset of Medalists was significantly correlated with self-reported longitudinal SD. SD in those with extreme-duration type 1 diabetes is independently associated with CVD, representing a large-vessel pattern. The findings suggest that SD may predict CVD in those with type 1 diabetes of long duration. These individuals have also been found to be relatively free of microvascular complications.
DOI: 10.2337/db10-0676
发表时间: 2010-11
期刊: Diabetes
影响因子: 7.7
作者:
Keenan HA;Sun JK;Levine J;Doria A;Aiello LP;Eisenbarth G;Bonner-Weir S;King GL
通讯作者: King GL
DOI: 10.1016/j.jdiacomp.2003.12.005
发表时间: 2005-01-01
影响因子: 3
作者:
Klein, R;Klein, BEK;Moss, SE
通讯作者: Moss, SE
DOI: 10.2337/diacare.9.5.443
发表时间: 1986-09-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
KROLEWSKI, AS;WARRAM, JH;KAHN, CR
通讯作者: KAHN, CR
DOI: 10.2337/dc06-2222
发表时间: 2007-08-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Keenan, Hillary A.;Costacou, Tina;King, George L.
通讯作者: King, George L.
DOI: 10.1038/sj.ijir.3900472
发表时间: 1999-12-01
影响因子: 2.6
作者:
Rosen, RC;Cappelleri, JC;Pe単a, BM
通讯作者: Pe単a, BM